[go: up one dir, main page]

FR2112483B1 - - Google Patents

Info

Publication number
FR2112483B1
FR2112483B1 FR7112703A FR7112703A FR2112483B1 FR 2112483 B1 FR2112483 B1 FR 2112483B1 FR 7112703 A FR7112703 A FR 7112703A FR 7112703 A FR7112703 A FR 7112703A FR 2112483 B1 FR2112483 B1 FR 2112483B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7112703A
Other versions
FR2112483A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAKAHASHI HITOSHI JA
Original Assignee
TAKAHASHI HITOSHI JA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAKAHASHI HITOSHI JA filed Critical TAKAHASHI HITOSHI JA
Publication of FR2112483A1 publication Critical patent/FR2112483A1/fr
Application granted granted Critical
Publication of FR2112483B1 publication Critical patent/FR2112483B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7112703A 1970-11-06 1971-04-09 Expired FR2112483B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9814670 1970-11-06

Publications (2)

Publication Number Publication Date
FR2112483A1 FR2112483A1 (fr) 1972-06-16
FR2112483B1 true FR2112483B1 (fr) 1975-06-06

Family

ID=14212042

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7112703A Expired FR2112483B1 (fr) 1970-11-06 1971-04-09

Country Status (3)

Country Link
DE (1) DE2117762A1 (fr)
FR (1) FR2112483B1 (fr)
GB (1) GB1342286A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
US4021538A (en) * 1975-09-29 1977-05-03 Yu Ruey J Method for producing pigmentation in hair or skin
IT1258069B (it) * 1992-04-10 1996-02-20 Composizione per uso topico avente attivita' di stimolo per la ricrescita, di rinvigorimento, di prevenzione dell'ingrigimento e di ripigmentazione naturale dei capelli
US6696600B2 (en) 2001-11-13 2004-02-24 Teva Pharmaceutical Industries, Ltd. L-DOPA ethyl ester salts and uses thereof
FR2847805B1 (fr) * 2002-11-28 2005-01-07 Oreal Procede de densification des fibres keratiniques humaines utilisant un systeme catalytique particulier
EP1348421A3 (fr) * 2002-03-25 2004-01-02 L'oreal Procédé de densification ou de coiffage des fibres kératiniques humaines utilisant un système catalytique particulier

Also Published As

Publication number Publication date
FR2112483A1 (fr) 1972-06-16
GB1342286A (en) 1974-01-03
DE2117762A1 (de) 1972-05-10

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
FR2112483B1 (fr)
ATA96471A (fr)
AU1146470A (fr)
AU2044470A (fr)
AU2130570A (fr)
AU1716970A (fr)
AU1833270A (fr)
AU2085370A (fr)
AR195465A1 (fr)
AU2131570A (fr)
AU1004470A (fr)
AU1277070A (fr)
AU2130770A (fr)
AU1247570A (fr)
AU2119370A (fr)
AU2115870A (fr)
AU2112570A (fr)
AU1591370A (fr)
AU2061170A (fr)
AU1235770A (fr)
AU1581370A (fr)
AU1974970A (fr)
AU1969370A (fr)
AU1943370A (fr)